ariel3: rucaparib as maintenance therapy in recurrent ovarian cancer patients
Published 7 years ago • 111 plays • Length 9:31Download video MP4
Download video MP3
Similar videos
-
3:11
rucaparib in recurrent ovarian cancer: ariel3 trial
-
9:22
rucaparib effective as maintenance therapy following first-line platinum-based chemo in ovarian ...
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
5:11
defining rucaparib’s value in recurrent ovarian cancer
-
5:04
rucaparib and ariel3 – positive results from the phase 3 trial in ovarian cancer patients
-
2:09
rucaparib maintenance for recurrent ovarian carcinoma
-
6:12
rucaparib for recurrent ovarian cancer
-
3:06
rucaparib maintenance therapy for high-risk ovarian cancer
-
1:20
dr. ledermann on rationale for ariel3 trial in ovarian cancer
-
4:25
rucaparib: clinical activity in relapsed ovarian cancer
-
1:45
comment: niraparib for ovarian cancer
-
1:21
rucaparib may improve pfs in patients with ovarian cancer
-
3:29
rucaparib boosts pfs in brca-mutated recurrent ovarian cancer
-
6:57
niraparib maintenance for recurrent ovarian cancer
-
2:16
biomarker for parp inhibitor responsiveness in ovarian cancer patients
-
3:07
rucaparib maintenance and monotherapy for ovarian cancer: trial updates
-
6:42
efficacy and safety of rucaparib: a focus on ariel3
-
11:05
parp inhibitors in recurrent ovarian cancer
-
1:48
niraparib maintenance therapy in ovarian cancer